I assume distribution. Hard to value a 1-approved-drug bio company with a not-yet-commercialized cure for a self-described 'rare condition' at 13B .
Also usually when things go up a lot they come down a bit first?
Mortgages tend to be right at the prime rate over time, falling a bit below or above (recent decades) depending on sentiment, but large diversions would be relatively unprecedented.
